-   directed: true
    graph:
        disease: Pituitary dwarfism
        disease_mesh: MESH:D004393
        drug: sermorelin
        drug_mesh: MESH:D017337
        drugbank: DB:DB00010
    links:
    -   key: increases activity of
        source: MESH:D017337
        target: UniProt:Q02643
    -   key: increases activity of
        source: UniProt:Q02643
        target: UniProt:P01241
    -   key: participates in
        source: UniProt:P01241
        target: GO:0060396
    -   key: increases activity of
        source: GO:0060396
        target: UniProt:P05019
    -   key: positively regulates
        source: UniProt:P05019
        target: GO:0035264
    -   key: negatively correlated with
        source: GO:0035264
        target: MESH:D004393
    multigraph: true
    nodes:
    -   id: MESH:D017337
        label: Drug
        name: Sermorelin
    -   id: UniProt:Q02643
        label: Protein
        name: Growth hormone-releasing hormone receptor
    -   id: UniProt:P01241
        label: Protein
        name: Somatotropin
    -   id: GO:0060396
        label: BiologicalProcess
        name: Growth hormone receptor signaling pathway
    -   id: UniProt:P05019
        label: Protein
        name: Insulin-like growth factor I
    -   id: GO:0035264
        label: BiologicalProcess
        name: Multicellular organism growth
    -   id: MESH:D004393
        label: Disease
        name: Pituitary dwarfism
    reference: 
    - https://go.drugbank.com/drugs/DB00010#BE0000625
-   comments: Withdrawn. Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia.
    directed: true
    graph:
        disease: Extrapyramidal disease
        disease_mesh: MESH:D001480
        drug: procyclidine
        drug_mesh: MESH:D011352
        drugbank: DB:DB00387
    links:
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P11229
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08172
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08173
    -   key: positively regulates
        source: UniProt:P11229
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08172
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08173
        target: GO:0007271
    -   key: positively correlated with
        source: GO:0007271
        target: HP:0100022
    -   key: manifestation of
        source: HP:0100022
        target: HP:0001300
    -   key: manifestation of
        source: HP:0001300
        target: MESH:D001480
    multigraph: true
    nodes:
    -   id: MESH:D011352
        label: Drug
        name: Procyclidine
    -   id: UniProt:P11229
        label: Protein
        name: Muscarinic acetylcholine receptor M1
    -   id: UniProt:P08172
        label: Protein
        name: Muscarinic acetylcholine receptor M2
    -   id: UniProt:P08173
        label: Protein
        name: Muscarinic acetylcholine receptor M4
    -   id: GO:0007271
        label: BiologicalProcess
        name: Synaptic transmission, cholinergic
    -   id: HP:0100022
        label: PhenotypicFeature
        name: Abnormality of movement
    -   id: HP:0001300
        label: PhenotypicFeature
        name: Parkinsonism
    -   id: MESH:D001480
        label: Disease
        name: Extrapyramidal disease
    reference:
    - https://go.drugbank.com/drugs/DB00387#BE0000560
    - https://en.wikipedia.org/wiki/Extrapyramidal_symptoms
-   comments: Withdrawn. Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia.
    directed: true
    graph:
        disease: Parkinsonism
        disease_mesh: MESH:D020734
        drug: procyclidine
        drug_mesh: MESH:D011352
        drugbank: DB:DB00387
    links:
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P11229
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08172
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08173
    -   key: positively regulates
        source: UniProt:P11229
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08172
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08173
        target: GO:0007271
    -   key: positively correlated with
        source: GO:0007271
        target: HP:0100022
    -   key: manifestation of
        source: HP:0100022
        target: HP:0001300
    -   key: manifestation of
        source: HP:0001300
        target: MESH:D020734
    multigraph: true
    nodes:
    -   id: MESH:D011352
        label: Drug
        name: Procyclidine
    -   id: UniProt:P11229
        label: Protein
        name: Muscarinic acetylcholine receptor M1
    -   id: UniProt:P08172
        label: Protein
        name: Muscarinic acetylcholine receptor M2
    -   id: UniProt:P08173
        label: Protein
        name: Muscarinic acetylcholine receptor M4
    -   id: GO:0007271
        label: BiologicalProcess
        name: Synaptic transmission, cholinergic
    -   id: HP:0100022
        label: PhenotypicFeature
        name: Abnormality of movement
    -   id: HP:0001300
        label: PhenotypicFeature
        name: Parkinsonism
    -   id: MESH:D020734
        label: Disease
        name: Parkinsonism
    reference:
    - https://go.drugbank.com/drugs/DB00387#BE0000560
-   comments: Withdrawn. Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia.
    directed: true
    graph:
        disease: Parkinson's disease
        disease_mesh: MESH:D010300
        drug: procyclidine
        drug_mesh: MESH:D011352
        drugbank: DB:DB00387
    links:
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P11229
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08172
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08173
    -   key: positively regulates
        source: UniProt:P11229
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08172
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08173
        target: GO:0007271
    -   key: positively correlated with
        source: GO:0007271
        target: HP:0100022
    -   key: manifestation of
        source: HP:0100022
        target: HP:0001300
    -   key: manifestation of
        source: HP:0001300
        target: MESH:D010300
    multigraph: true
    nodes:
    -   id: MESH:D011352
        label: Drug
        name: Procyclidine
    -   id: UniProt:P11229
        label: Protein
        name: Muscarinic acetylcholine receptor M1
    -   id: UniProt:P08172
        label: Protein
        name: Muscarinic acetylcholine receptor M2
    -   id: UniProt:P08173
        label: Protein
        name: Muscarinic acetylcholine receptor M4
    -   id: GO:0007271
        label: BiologicalProcess
        name: Synaptic transmission, cholinergic
    -   id: HP:0100022
        label: PhenotypicFeature
        name: Abnormality of movement
    -   id: HP:0001300
        label: PhenotypicFeature
        name: Parkinsonism
    -   id: MESH:D010300
        label: Disease
        name: Parkinson's disease
    reference:
    - https://go.drugbank.com/drugs/DB00387#BE0000560
-   comments: Withdrawn. Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia.
    directed: true
    graph:
        disease: Postencephalitic parkinsonism
        disease_mesh: MESH:D010301
        drug: procyclidine
        drug_mesh: MESH:D011352
        drugbank: DB:DB00387
    links:
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P11229
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08172
    -   key: negatively regulates
        source: MESH:D011352
        target: UniProt:P08173
    -   key: positively regulates
        source: UniProt:P11229
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08172
        target: GO:0007271
    -   key: positively regulates
        source: UniProt:P08173
        target: GO:0007271
    -   key: positively correlated with
        source: GO:0007271
        target: HP:0100022
    -   key: manifestation of
        source: HP:0100022
        target: HP:0001300
    -   key: manifestation of
        source: HP:0001300
        target: MESH:D010301
    multigraph: true
    nodes:
    -   id: MESH:D011352
        label: Drug
        name: Procyclidine
    -   id: UniProt:P11229
        label: Protein
        name: Muscarinic acetylcholine receptor M1
    -   id: UniProt:P08172
        label: Protein
        name: Muscarinic acetylcholine receptor M2
    -   id: UniProt:P08173
        label: Protein
        name: Muscarinic acetylcholine receptor M4
    -   id: GO:0007271
        label: BiologicalProcess
        name: Synaptic transmission, cholinergic
    -   id: HP:0100022
        label: PhenotypicFeature
        name: Abnormality of movement
    -   id: HP:0001300
        label: PhenotypicFeature
        name: Parkinsonism
    -   id: MESH:D010301
        label: Disease
        name: Postencephalitic parkinsonism
    reference:
    - https://go.drugbank.com/drugs/DB00387#BE0000560
-   comment: Withdrawn. Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. 
       Etretinate is now used to treat T-cell lymphomas.
    directed: true
    graph:
        disease: Psoriasis
        disease_mesh: MESH:D011565
        drug: etretinate
        drug_mesh: MESH:D005050
        drugbank: DB:DB00926
    links:
    -   key: increases activity of
        source: MESH:D005050
        target: UniProt:P10276
    -   key: increases activity of
        source: MESH:D005050
        target: UniProt:P10826
    -   key: increases activity of
        source: MESH:D005050
        target: UniProt:P19793
    -   key: increases activity of
        source: MESH:D005050
        target: UniProt:P48443
    -   key: negatively regulates
        source: UniProt:P10276
        target: GO:0031424
    -   key: negatively regulates
        source: UniProt:P19793
        target: GO:0031424
    -   key: negatively regulates
        source: UniProt:P10826
        target: GO:0031424
    -   key: negatively regulates
        source: UniProt:P48443
        target: GO:0031424
    -   key: negatively regulates
        source: UniProt:P10276
        target: GO:0010481
    -   key: negatively regulates
        source: UniProt:P19793
        target: GO:0010481
    -   key: negatively regulates
        source: UniProt:P10826
        target: GO:0010481
    -   key: negatively regulates
        source: UniProt:P48443
        target: GO:0010481
    -   key: positively correlated with
        source: GO:0031424
        target: MESH:D011565
    -   key: positively correlated with
        source: GO:0010481
        target: MESH:D011565
    multigraph: true
    nodes:
    -   id: MESH:D005050
        label: Drug
        name: Etretinate
    -   id: UniProt:P10276
        label: Protein
        name: Retinoic acid receptor alpha
    -   id: UniProt:P10826
        label: Protein
        name: Retinoic acid receptor beta
    -   id: UniProt:P19793
        label: Protein
        name: Retinoic acid receptor RXR-alpha
    -   id: UniProt:P48443
        label: Protein
        name: Retinoic acid receptor RXR-gamma
    -   id: GO:0031424
        label: BiologicalProcess
        name: Keratinization
    -   id: GO:0010481
        label: BiologicalProcess
        name: Epidermal cell division
    -   id: MESH:D011565
        label: Disease
        name: Psoriasis
    reference: 
    - https://go.drugbank.com/drugs/DB00926
-   directed: true
    graph:
        disease: Shigellosis
        disease_mesh: MESH:D004405
        drug: sulfamethizole
        drug_mesh: MESH:D013419
        drugbank: DB:DB00576
    links:
    -   key: decreases activity of
        source: MESH:D013419
        target: Pfam:PF00809
    -   key: positively regulates
        source: Pfam:PF00809
        target: GO:0046654
    -   key: positively regulates
        source: GO:0046654
        target: GO:0009113
    -   key: positively regulates
        source: GO:0009113
        target: GO:0071897
    -   key: part of
        source: GO:0071897
        target: GO:0051301
    -   key: occurs in
        source: GO:0051301
        target: NCBITaxon:620
    -   key: causes
        source: NCBITaxon:620
        target: MESH:D004405
    multigraph: true
    nodes:
    -   id: MESH:D013419
        label: Drug
        name: Sulfamethizole
    -   id: Pfam:PF00809
        label: GeneFamily
        name: Dihydropteroate synthase
    -   id: GO:0046654
        label: BiologicalProcess
        name: Tetrahydrofolate biosynthetic process
    -   id: GO:0009113
        label: BiologicalProcess
        name: Purine nucleobase biosynthetic process
    -   id: GO:0071897
        label: BiologicalProcess
        name: DNA biosynthetic process
    -   id: GO:0051301
        label: BiologicalProcess
        name: Cell division
    -   id: NCBITaxon:620
        label: OrganismTaxon
        name: Shigella
    -   id: MESH:D004405
        label: Disease
        name: Shigellosis
    reference: https://go.drugbank.com/drugs/DB00576#BE0000803
-   comment: Premature ejaculation is treated with combination of lidocaine and prilocaine cream.
    directed: true
    graph:
        disease: Premature ejaculation
        disease_mesh: MESH:D061686
        drug: prilocaine
        drug_mesh: MESH:D011318
        drugbank: DB:DB00750
    links:
    -   key: treats
        source: MESH:D011318
        target: MESH:D061686
    multigraph: true
    nodes:
    -   id: MESH:D011318
        label: Drug
        name: Prilocaine
    -   id: MESH:D061686
        label: Disease
        name: Premature ejaculation
    reference: 
    - https://go.drugbank.com/drugs/DB00750
    - https://pubmed.ncbi.nlm.nih.gov/12472618/
-   directed: true
    graph:
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
        drug: nadolol
        drug_mesh: MESH:D009248
        drugbank: DB:DB01203
    links:
    -   key: decreases activity of
        source: MESH:D009248
        target: UniProt:P08588
    -   key: positively regulates
        source: UniProt:P08588
        target: HP:0033533
    -   key: positively regulates
        source: UniProt:P08588
        target: UniProt:P00797
    -   key: positively regulates
        source: UniProt:P00797
        target: GO:0042310
    -   key: affects risk for
        source: GO:0042310
        target: HP:0000822
    -   key: positively correlated with
        source: HP:0000822
        target: MESH:D006973
    -   key: positively correlated with
        source: HP:0033533
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:D009248
        label: Drug
        name: Nadolol
    -   id: UniProt:P08588
        label: Protein
        name: Beta-1 adrenergic receptor
    -   id: HP:0033533
        label: PhenotypicFeature
        name: Increased cardiac output
    -   id: UniProt:P00797
        label: Protein
        name: Renin
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Hypertension
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference:
    - https://go.drugbank.com/drugs/DB01203
-   directed: true
    graph:
        disease: Angina pectoris
        disease_mesh: MESH:D000787
        drug: nadolol
        drug_mesh: MESH:D009248
        drugbank: DB:DB01203
    links:
    -   key: decreases activity of
        source: MESH:D009248
        target: UniProt:P08588
    -   key: positively regulates
        source: UniProt:P08588
        target: HP:0033533
    -   key: positively regulates
        source: UniProt:P08588
        target: UniProt:P00797
    -   key: positively regulates
        source: UniProt:P00797
        target: GO:0042310
    -   key: affects risk for
        source: GO:0042310
        target: HP:0000822
    -   key: contributes to
        source: HP:0000822
        target: MESH:D000787
    -   key: positively correlated with
        source: HP:0033533
        target: MESH:D000787
    multigraph: true
    nodes:
    -   id: MESH:D009248
        label: Drug
        name: Nadolol
    -   id: UniProt:P08588
        label: Protein
        name: Beta-1 adrenergic receptor
    -   id: HP:0033533
        label: PhenotypicFeature
        name: Increased cardiac output
    -   id: UniProt:P00797
        label: Protein
        name: Renin
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Hypertension
    -   id: MESH:D000787
        label: Disease
        name: Angina pectoris
    reference:
    - https://go.drugbank.com/drugs/DB01203
-   directed: true
    graph:
        disease: Juvenile idiopathic arthritis
        disease_mesh: MESH:D001171
        drug: abatacept
        drug_mesh: MESH:D000069594
        drugbank: DB:DB01281
    links:
    -   key: decreases activity of
        source: MESH:D000069594
        target: UniProt:P33681
    -   key: decreases activity of
        source: MESH:D000069594
        target: UniProt:P42081 
    -   key: increases activity of
        source: UniProt:P33681
        target: UniProt:P10747
    -   key: increases activity of
        source: UniProt:P42081
        target: UniProt:P10747
    -   key: participates in
        source: UniProt:P10747
        target: GO:0032743
    -   key: participates in
        source: UniProt:P10747
        target: GO:0042102
    -   key: participates in
        source: UniProt:P10747
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0032743
        target: MESH:D001171
    -   key: positively correlated with
        source: GO:0042110
        target: MESH:D001171
    -   key: positively correlated with
        source: GO:0042102
        target: MESH:D001171
    multigraph: true
    nodes:
    -   id: MESH:D000069594
        label: Drug
        name: Abatacept
    -   id: UniProt:P33681
        label: Protein
        name: T-lymphocyte activation antigen CD80
    -   id: UniProt:P42081
        label: Protein
        name: T-lymphocyte activation antigen CD86
    -   id: UniProt:P10747
        label: Protein
        name: T-cell-specific surface glycoprotein CD28
    -   id: GO:0032743
        label: BiologicalProcess
        name: Positive regulation of interleukin-2 production
    -   id: GO:0042102
        label: BiologicalProcess
        name: Positive regulation of T cell proliferation
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: MESH:D001171
        label: Drug
        name: Juvenile idiopathic arthritis
    reference:
    - https://go.drugbank.com/drugs/DB01281#BE0000847
    - https://en.wikipedia.org/wiki/Abatacept
-   directed: true
    graph:
        disease: Rheumatoid arthritis
        disease_mesh: MESH:D001172
        drug: abatacept
        drug_mesh: MESH:D000069594
        drugbank: DB:DB01281
    links:
    -   key: decreases activity of
        source: MESH:D000069594
        target: UniProt:P33681
    -   key: decreases activity of
        source: MESH:D000069594
        target: UniProt:P42081 
    -   key: increases activity of
        source: UniProt:P33681
        target: UniProt:P10747
    -   key: increases activity of
        source: UniProt:P42081
        target: UniProt:P10747
    -   key: participates in
        source: UniProt:P10747
        target: GO:0032743
    -   key: participates in
        source: UniProt:P10747
        target: GO:0042102
    -   key: participates in
        source: UniProt:P10747
        target: GO:0042110
    -   key: positively correlated with
        source: GO:0032743
        target: MESH:D001172
    -   key: positively correlated with
        source: GO:0042110
        target: MESH:D001172
    -   key: positively correlated with
        source: GO:0042102
        target: MESH:D001172
    multigraph: true
    nodes:
    -   id: MESH:D000069594
        label: Drug
        name: Abatacept
    -   id: UniProt:P33681
        label: Protein
        name: T-lymphocyte activation antigen CD80
    -   id: UniProt:P42081
        label: Protein
        name: T-lymphocyte activation antigen CD86
    -   id: UniProt:P10747
        label: Protein
        name: T-cell-specific surface glycoprotein CD28
    -   id: GO:0032743
        label: BiologicalProcess
        name: Positive regulation of interleukin-2 production
    -   id: GO:0042102
        label: BiologicalProcess
        name: Positive regulation of T cell proliferation
    -   id: GO:0042110
        label: BiologicalProcess
        name: T cell activation
    -   id: MESH:D001172
        label: Drug
        name: Rheumatoid arthritis
    reference:
    - https://go.drugbank.com/drugs/DB01281#BE0000847
    - https://en.wikipedia.org/wiki/Abatacept
-   directed: true
    graph:
        disease: Low blood pressure
        disease_mesh: MESH:D007022
        drug: mephentermine
        drug_mesh: MESH:D008616
        drugbank: DB:DB01365
    links:
    -   key: increases activity of
        source: MESH:D008616
        target: UniProt:P35348
    -   key: increases activity of
        source: MESH:D008616
        target: UniProt:P35368
    -   key: increases activity of
        source: MESH:D008616
        target: UniProt:P25100
    -   key: increases activity of
        source: MESH:D008616
        target: UniProt:P08588
    -   key: positively regulates
        source: UniProt:P35348
        target: GO:0042310
    -   key: positively regulates
        source: UniProt:P35368
        target: GO:0042310
    -   key: positively regulates
        source: UniProt:P25100
        target: GO:0042310
    -   key: positively regulates
        source: UniProt:P08588
        target: GO:0060048
    -   key: negatively correlated with
        source: GO:0042310
        target: MESH:D007022
    -   key: negatively correlated with
        source: GO:0060048
        target: MESH:D007022
    -   key: positively regulates
        source: MESH:D008616
        target: GO:0061533
    -   key: negatively correlated with
        source: GO:0061533
        target: MESH:D007022 
    multigraph: true
    nodes:
    -   id: MESH:D008616
        label: Drug
        name: Mephentermine
    -   id: UniProt:P35348
        label: Protein
        name: Alpha-1A adrenergic receptor
    -   id: UniProt:P35368
        label: Protein
        name: Alpha-1B adrenergic receptor
    -   id: UniProt:P25100
        label: Protein
        name: Alpha-1D adrenergic receptor
    -   id: UniProt:P08588
        label: Protein
        name: Beta-1 adrenergic receptor
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: GO:0060048
        label: BiologicalProcess
        name: Cardiac muscle contraction
    -   id: GO:0061533
        label: BiologicalProcess
        name: Norepinephrine secretion, neurotransmission
    -   id: MESH:D007022
        label: Disease
        name: Low blood pressure
    reference: 
    - https://go.drugbank.com/drugs/DB01365#BE0004872
    - https://en.wikipedia.org/wiki/Mephentermine
-   directed: true
    graph:
        disease: Chronic non-neuropathic Gaucher's disease
        disease_mesh: MESH:D005776
        drug: taliglucerase alfa
        drug_mesh: MESH:C582473
        drugbank: DB:DB08876
    links:
    -   key: decreases abundance of
        source: MESH:C582473
        target: MESH:D005963
    -   key: causes
        source: MESH:D005963
        target: MESH:D005776
    multigraph: true
    nodes:
    -   id: MESH:C582473
        label: Drug
        name: Taliglucerase alfa
    -   id: MESH:D005963
        label: ChemicalSubstance
        name: Glucosylceramides
    -   id: MESH:D005776
        label: Disease
        name: Chronic non-neuropathic Gaucher's disease
    reference:
    - https://en.wikipedia.org/wiki/Gaucher%27s_disease
    - https://go.drugbank.com/drugs/DB08876
-   directed: true
    graph:
        disease: Diabetes mellitus type 2
        disease_mesh: MESH:D003924
        drug: albiglutide
        drug_mesh: MESH:C534611
        drugbank: DB:DB09043
    links:
    -   key: increases activity of
        source: MESH:C534611
        target: UniProt:P43220
    -   key: positively correlated with
        source: UniProt:P43220
        target: CHEBI:80270
    -   key: positively regulates
        source: CHEBI:80270
        target: GO:0030073
    -   key: negatively regulates
        source: CHEBI:80270
        target: GO:0070091
    -   key: negatively regulates
        source: GO:0030073
        target: HP:0003074
    -   key: positively correlated with
        source: GO:0070091
        target: HP:0003074
    -   key: manifestation of
        source: HP:0003074
        target: MESH:D003924
    multigraph: true
    nodes:
    -   id: MESH:C534611
        label: Drug
        name: Albiglutide
    -   id: UniProt:P43220
        label: Protein
        name: Glucagon-like peptide 1 receptor
    -   id: CHEBI:80270
        label: ChemicalSubstance
        name: Glucagon-like peptide 1
    -   id: GO:0030073
        label: BiologicalProcess
        name: Insulin secretion
    -   id: GO:0070091
        label: BiologicalProcess
        name: Glucagon secretion
    -   id: HP:0003074
        label: PhenotypicFeature
        name: Hyperglycemia
    -   id: MESH:D003924
        label: Disease
        name: Diabetes mellitus type 2
    reference:
    - https://go.drugbank.com/drugs/DB09043
    - https://en.wikipedia.org/wiki/Glucagon-like_peptide-1
-   comment: Selective action of tamsulosin in alpha 1A/D receptors is controversial and over three quarters of tamsulosin registered human studies are unpublished.
    directed: true
    graph:
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
        drug: trimazosin
        drug_mesh: MESH:C005185
        drugbank: DB:DB09206
    links:
    -   key: decreases activity of
        source: MESH:C005185
        target: UniProt:P35348
    -   key: decreases activity of
        source: MESH:C005185
        target: UniProt:P25100
    -   key: positively regulates
        source: UniProt:P35348
        target: GO:0042310
    -   key: positively regulates
        source: UniProt:P25100
        target: GO:0042310
    -   key: affects risk for
        source: GO:0042310
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:C005185
        label: Drug
        name: Trimazosin
    -   id: UniProt:P35348
        label: Protein
        name: Alpha-1A adrenergic receptor
    -   id: UniProt:P25100
        label: Protein
        name: Alpha-1D adrenergic receptor
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference:
    - https://en.wikipedia.org/wiki/Tamsulosin
    - https://go.drugbank.com/drugs/DB09206
-   directed: true
    graph:
        disease: Staphylococcal infection of skin
        disease_mesh: MESH:D013207
        drug: Ozenoxacin
        drug_mesh: MESH:C000592413
        drugbank: DB:DB12924
    links:
    -   key: decreases activity of
        source: MESH:C000592413
        target: UniProt:P0C1U9
    -   key: decreases activity of
        source: MESH:C000592413
        target: UniProt:Q2FKQ0
    -   key: participates in
        source: UniProt:P0C1U9
        target: GO:0044787
    -   key: participates in
        source: UniProt:Q2FKQ0
        target: GO:0044787
    -   key: occurs in
        source: GO:0044787
        target: NCBITaxon:1280
    -   key: causes
        source: NCBITaxon:1280
        target: MESH:D013207
    multigraph: true
    nodes:
    -   id: MESH:C000592413
        label: Drug
        name: Ozenoxacin
    -   id: UniProt:P0C1U9
        label: Protein
        name: DNA topoisomerase 4 subunit A (Staphylococcus aureus)
    -   id: UniProt:Q2FKQ0
        label: Protein
        name: DNA gyrase subunit A (Staphylococcus aureus)
    -   id: GO:0044787
        label: BiologicalProcess
        name: Bacterial-type DNA replication
    -   id: NCBITaxon:1280
        label: OrganismTaxon
        name: Staphylococcus aureus
    -   id: MESH:D013207
        label: Disease
        name: Staphylococcal infection of skin
    reference:
    - https://go.drugbank.com/drugs/DB12924
-   directed: true
    graph:
        disease: Acne vulgaris
        disease_mesh: MESH:D000152
        drug: Ozenoxacin
        drug_mesh: MESH:C000592413
        drugbank: DB:DB12924
    links:
    -   key: decreases activity of
        source: MESH:C000592413
        target: InterPro:IPR035516
    -   key: decreases activity of
        source: MESH:C000592413
        target: InterPro:IPR013760
    -   key: participates in
        source: InterPro:IPR035516
        target: GO:0044787
    -   key: participates in
        source: InterPro:IPR013760
        target: GO:0044787
    -   key: occurs in
        source: GO:0044787
        target: NCBITaxon:1747
    -   key: causes
        source: NCBITaxon:1747
        target: MESH:D000152
    multigraph: true
    nodes:
    -   id: MESH:C000592413
        label: Drug
        name: Ozenoxacin
    -   id: InterPro:IPR035516
        label: GeneFamily
        name: DNA gyrase/topoisomerase IV, subunit A, C-terminal
    -   id: InterPro:IPR013760
        label: GeneFamily
        name: DNA topoisomerase, type IIA-like domain superfamily
    -   id: GO:0044787
        label: BiologicalProcess
        name: Bacterial-type DNA replication
    -   id: NCBITaxon:1747
        label: OrganismTaxon
        name: Cutibacterium acnes
    -   id: MESH:D000152
        label: Disease
        name: Acne vulgaris
    reference:
    - https://go.drugbank.com/drugs/DB12924
    - https://en.wikipedia.org/wiki/Acne#Infections
-   directed: true
    graph:
        disease: Schizophrenia
        disease_mesh: MESH:D012559
        drug: thiothixene
        drug_mesh: MESH:D013888
        drugbank: DB:DB01623
    links:
    -   key: decreases activity of
        source: MESH:D013888
        target: UniProt:P14416
    -   key: decreases activity of
        source: MESH:D013888
        target: UniProt:P28223
    -   key: participates in
        source: UniProt:P14416
        target: GO:1903350
    -   key: participates in
        source: UniProt:P28223
        target: GO:1904014
    -   key: correlated with
        source: GO:1903350
        target: MESH:D012559
    -   key: correlated with
        source: GO:1904014
        target: MESH:D012559
    multigraph: true
    nodes:
    -   id: MESH:D013888
        label: Drug
        name: Thiothixene
    -   id: UniProt:P14416
        label: Protein
        name: Dopamine D2 receptor
    -   id: UniProt:P28223
        label: Protein
        name: 5-hydroxytryptamine receptor 2A
    -   id: GO:1903350
        label: BiologicalProcess
        name: response to dopamine
    -   id: GO:1904014
        label: BiologicalProcess
        name: response to serotonin
    -   id: MESH:D012559
        label: Disease
        name: Schizophrenia
    reference:
    - https://go.drugbank.com/drugs/DB01623
    - https://pubmed.ncbi.nlm.nih.gov/27189524/
    - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255483/
    - https://en.wikipedia.org/wiki/Tiotixene
    - https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201/
-   comment:  No evidence found to support Ascorbic acid deficiency treatment with  calcium pantothenate.
    directed: true
    graph:
        disease: Ascorbic acid deficiency
        disease_mesh: MESH:D001206
        drug: calcium pantothenate
        drug_mesh: MESH:D010205
        drugbank: DB:DB01783
    links:
    -   key: treats
        source: MESH:D010205
        target: MESH:D001206
    multigraph: true
    nodes:
    -   id: MESH:D010205
        label: Drug
        name: Calcium pantothenate
    -   id: MESH:D001206
        label: Disease
        name: Ascorbic acid deficiency
    reference: https://go.drugbank.com/drugs/DB01783
